InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

CYCN Insider Trading

Insider Ownership Percentage: 13.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $27.20

Cyclerion Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cyclerion Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cyclerion Therapeutics Share Price & Price History

Current Price: $2.25
Price Change: ▲ Price Increase of +0.34 (17.80%)
As of 11/28/2023 01:00 AM ET

This chart shows the closing price history over time for CYCN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
An Unusual Way to Invest in Gold
From Edge On The Street   |   Ad
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
See why this overlooked gold play

Cyclerion Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/9/2023Terrance McguireDirectorSell8$3.40$27.20552View SEC Filing Icon  
6/3/2021Peter M. HechtCEOBuy41,158$65.60$2,699,964.80102,384View SEC Filing Icon  
6/3/2021Slate Path Capital LpMajor ShareholderBuy48,076$62.40$2,999,942.40View SEC Filing Icon  
6/3/2021Terrance McguireDirectorBuy4,807$62.40$299,956.80552View SEC Filing Icon  
5/6/2021Peter M. HechtCEOBuy15,100$48.60$733,860.0061,226View SEC Filing Icon  
5/4/2021Peter M. HechtCEOBuy15,000$45.80$687,000.0026,226View SEC Filing Icon  
12/28/2020Mark G CurrieInsiderSell1,005$60.20$60,501.0012,582View SEC Filing Icon  
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Cyclerion Therapeutics (NASDAQ:CYCN)

62.84% of Cyclerion Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CYCN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cyclerion Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2023Tyndall Capital Partners L P147,712$0.51M100.0%N/A6.129%Search for SEC Filing on Google Icon
8/15/2023Captrust Financial Advisors14,631$60K0.0%-95.0%0.607%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.18,000$74K0.0%-95.0%0.747%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC29,722$0.12M0.0%-95.0%1.233%Search for SEC Filing on Google Icon
8/11/2023Artal Group S.A.138,955$0.57M0.0%-95.0%5.766%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC592,237$0.26M0.0%+0.9%1.361%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC86,700$38K0.0%-52.8%0.199%Search for SEC Filing on Google Icon
2/15/2023Virtu Financial LLC48,524$32K0.0%N/A0.112%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC183,580$0.12M0.0%-35.2%0.422%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP36,600$31K0.0%-62.2%0.084%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.1,650,704$1.42M0.0%-5.9%3.795%Search for SEC Filing on Google Icon
11/15/2022Prelude Capital Management LLC92,541$80K0.0%-26.7%0.213%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC283,388$0.24M0.0%-37.9%0.652%Search for SEC Filing on Google Icon
8/24/2022Prelude Capital Management LLC126,192$69K0.0%+25.9%0.290%Search for SEC Filing on Google Icon
8/16/2022Jane Street Group LLC58,292$32K0.0%N/A0.134%Search for SEC Filing on Google Icon
8/16/2022Prudential Financial Inc.52,270$29K0.0%N/A0.120%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC51,589$28K0.0%-66.8%0.119%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC456,077$0.25M0.0%+50.7%1.050%Search for SEC Filing on Google Icon
8/12/2022FMR LLC2,537,723$1.39M0.0%-3.0%5.841%Search for SEC Filing on Google Icon
8/12/2022Franklin Resources Inc.77,993$43K0.0%-32.6%0.180%Search for SEC Filing on Google Icon
5/16/2022Prelude Capital Management LLC100,255$0.11M0.0%+29.2%0.231%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC302,558$0.34M0.0%-12.5%0.696%Search for SEC Filing on Google Icon
5/13/2022Mackenzie Financial Corp25,309$28K0.0%N/A0.058%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,754,153$1.95M0.0%-6.2%4.037%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP45,058$50K0.0%-63.0%0.104%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC231,952$0.26M0.0%-7.1%0.534%Search for SEC Filing on Google Icon
5/9/2022Trustcore Financial Services LLC292,645$0.33M0.0%+47.7%0.674%Search for SEC Filing on Google Icon
2/14/2022Diametric Capital LP100,480$0.17M0.1%+43.9%0.232%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC249,792$0.43M0.0%N/A0.577%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP647,700$1.99M0.0%+98.4%1.495%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP390,596$1.20M0.0%+154.1%0.902%Search for SEC Filing on Google Icon
11/15/2021Pura Vida Investments LLC422,311$1.30M0.0%-16.8%0.975%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP371,955$1.14M0.1%N/A0.859%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.116,035$0.36M0.0%N/A0.268%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC52,000$0.16M0.0%N/A0.120%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC490,660$1.51M0.0%+27.5%1.134%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC80,384$0.31M0.0%-9.2%0.186%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC12,596$49K0.0%-52.0%0.029%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP28,863$0.11M0.0%N/A0.067%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC509,924$1.99M0.2%+70.0%1.178%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC389,041$1.52M0.0%N/A0.899%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC66,977$0.26M0.0%+96.3%0.155%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC17,084$67K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/16/2021Diametric Capital LP80,336$0.31M0.2%N/A0.186%Search for SEC Filing on Google Icon
8/16/2021Slate Path Capital LP7,157,601$27.92M1.6%+15.5%16.539%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.129,628$0.51M0.0%-35.1%0.300%Search for SEC Filing on Google Icon
8/16/2021State Street Corp83,321$0.33M0.0%-79.2%0.193%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd85,000$0.33M0.1%N/A0.196%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.36,317$0.14M0.0%-9.4%0.084%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP28,863$0.11M0.0%N/A0.067%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC284,744$1.11M0.0%+22.1%0.658%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp64,616$0.25M0.0%-73.0%0.149%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC384,820$1.50M0.0%-21.0%0.889%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,423,532$5.55M0.0%-14.7%3.289%Search for SEC Filing on Google Icon
8/13/2021FMR LLC2,674,811$10.43M0.0%-1.9%6.181%Search for SEC Filing on Google Icon
8/12/2021Prime Capital Investment Advisors LLC22,250$87K0.0%N/A0.051%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd17,968$70K0.0%+34.4%0.042%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP158,994$0.62M0.0%+160.1%0.367%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.59,786$0.23M0.0%-43.7%0.138%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC96,100$0.38M0.0%N/A0.222%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp66,792$0.26M0.0%-31.9%0.154%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG65,900$0.26M0.0%-18.7%0.152%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC105,572$0.41M0.0%N/A0.244%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC88,551$0.25M0.0%N/A0.259%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.68,472$0.19M0.0%-62.2%0.201%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC42,900$0.12M0.0%+74.4%0.126%Search for SEC Filing on Google Icon
5/17/2021Walleye Trading LLC10,000$28K0.0%N/A0.029%Search for SEC Filing on Google Icon
5/17/2021Walleye Capital LLC15,000$42K0.0%N/A0.044%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC300,000$0.84M0.0%N/A0.879%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd13,365$37K0.0%N/A0.039%Search for SEC Filing on Google Icon
5/13/2021QS Investors LLC116,035$0.32M0.0%+13.1%0.340%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC18,516$52K0.0%+159.0%0.054%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC233,200$0.65M0.0%+1,202.8%0.683%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp239,015$0.67M0.0%-7.0%0.700%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC486,959$1.36M0.0%+12.2%1.427%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.106,102$0.30M0.0%+19.1%0.311%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund12,070$34K0.0%-91.0%0.035%Search for SEC Filing on Google Icon
5/10/2021Russell Investments Group Ltd.124,075$0.35M0.0%+400.2%0.363%Search for SEC Filing on Google Icon
5/10/2021Bank Julius Baer & Co. Ltd Zurich12,000$33K0.0%-33.2%0.035%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,685,485$4.70M0.0%+5.1%4.938%Search for SEC Filing on Google Icon
4/28/2021DAVENPORT & Co LLC84,500$0.24M0.0%+369.0%0.248%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP63,735$0.20M0.0%+8.7%0.187%Search for SEC Filing on Google Icon
3/1/2021UBS Asset Management Americas Inc.10,149$31K0.0%-58.8%0.030%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP63,735$0.20M0.0%+8.7%0.188%Search for SEC Filing on Google Icon
2/24/2021Bank Julius Baer & Co. Ltd Zurich17,974$55K0.0%N/A0.053%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.89,079$0.27M0.0%+84.8%0.262%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.177,091$0.54M0.0%-6.5%0.521%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp257,044$0.79M0.0%-3.4%0.757%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers34,065$0.10M0.0%+15.8%0.100%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC17,900$55K0.0%N/A0.053%Search for SEC Filing on Google Icon
2/10/2021QS Investors LLC102,600$0.31M0.0%N/A0.302%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN50,522$0.15M0.0%+77.9%0.149%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp100,061$0.31M0.0%+13.2%0.295%Search for SEC Filing on Google Icon
2/8/2021Alliancebernstein L.P.31,800$97K0.0%-6.5%0.094%Search for SEC Filing on Google Icon
2/8/2021NorthRock Partners LLC10,000$31K0.0%N/A0.029%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund133,709$0.41M0.0%-5.8%0.394%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.1,604,118$4.91M0.0%+5.3%4.723%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP23,335$71K0.0%N/A0.069%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC10,312$63K0.0%N/A0.030%Search for SEC Filing on Google Icon
11/17/2020California State Teachers Retirement System33,518$0.20M0.0%-9.9%0.099%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cyclerion Therapeutics logo
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is Zagociguat (CY6463), a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's disease with vascular pathology; and Phase 1 trials diagnosed with schizophrenia in adults. It is also developing Praliciguat, an orally administered systemic sGC stimulator, which is in Phase II studies to treat resistant hypertension and diabetic nephropathy; Olinciguat, an orally administered vascular sGC stimulator that is in Phase II studies for the sickle cell disease; and CY3018, a CNS-targeted sGC stimulator that is in preclinical trial for the treatment of neuropsychiatric diseases and disorders. It has license agreement with Akebia Therapeutics, Inc. for the development, manufacture, medical affairs, and commercialization of pharmaceutical products, including pharmaceutical compound, and other related products and forms. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Read More on Cyclerion Therapeutics

Today's Range

Now: $2.25
Low: $1.75
High: $2.25

50 Day Range

MA: $2.87
Low: $1.90
High: $3.79

52 Week Range

Now: $2.25
Low: $1.75
High: $19.66

Volume

5,181 shs

Average Volume

4,013 shs

Market Capitalization

$5.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.89

Who are the company insiders with the largest holdings of Cyclerion Therapeutics?

Cyclerion Therapeutics' top insider shareholders include:
  1. Terrance Mcguire (Director)
Learn More about top insider investors at Cyclerion Therapeutics.

Who are the major institutional investors of Cyclerion Therapeutics?

Cyclerion Therapeutics' top institutional investors include:
  1. Tyndall Capital Partners L P — 6.13%
  2. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Cyclerion Therapeutics stock.

Which major investors are buying Cyclerion Therapeutics stock?

In the last quarter, CYCN stock was bought by institutional investors including:
  1. Tyndall Capital Partners L P
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.